Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 8
1998 6
1999 5
2000 4
2001 4
2002 2
2003 4
2004 4
2005 2
2006 2
2007 5
2008 5
2009 4
2010 9
2011 11
2012 11
2013 2
2014 1
2015 5
2016 6
2017 6
2018 2
2019 3
2020 6
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Results by year
Filters applied: . Clear all
Page 1
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.
Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Keyaerts M, et al. Among authors: everaert h. J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449837 Free article. Clinical Trial.
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.
Duerinck J, Schwarze JK, Awada G, Tijtgat J, Vaeyens F, Bertels C, Geens W, Klein S, Seynaeve L, Cras L, D'Haene N, Michotte A, Caljon B, Salmon I, Bruneau M, Kockx M, Van Dooren S, Vanbinst AM, Everaert H, Forsyth R, Neyns B. Duerinck J, et al. Among authors: everaert h. J Immunother Cancer. 2021 Jun;9(6):e002296. doi: 10.1136/jitc-2020-002296. J Immunother Cancer. 2021. PMID: 34168003 Free PMC article. Clinical Trial.
Selective spleen SPECT/CT.
Ceulemans G, Sermeus A, Verdries D, Keyaerts M, Ilsen B, Kichouch M, De Ridder M, Everaert H. Ceulemans G, et al. Among authors: everaert h. JBR-BTR. 2011 Nov-Dec;94(6):353. doi: 10.5334/jbr-btr.709. JBR-BTR. 2011. PMID: 22338722 No abstract available.
PSMA Uptake in Mediastinal Sarcoidosis.
Ardies PJ, Gykiere P, Goethals L, De Mey J, De Geeter F, Everaert H. Ardies PJ, et al. Among authors: everaert h. Clin Nucl Med. 2017 Apr;42(4):303-305. doi: 10.1097/RLU.0000000000001543. Clin Nucl Med. 2017. PMID: 28114227
Nuclear cardiology, Part IV: Viability.
Mesotten L, Maes A, Hambye AS, Everaert H, Van den Maegdenbergh V, Franken P, Mortelmans L. Mesotten L, et al. Among authors: everaert h. J Nucl Med Technol. 1999 Jun;27(2):93-102; quiz 104-5. J Nucl Med Technol. 1999. PMID: 10353105 Free article. Review.
Helical CT of Rib Lesions: A Pattern-Based Approach.
De Maeseneer M, De Mey J, Lenchik L, Everaert H, Osteaux M. De Maeseneer M, et al. Among authors: everaert h. AJR Am J Roentgenol. 2004 Jan;182(1):173-9. doi: 10.2214/ajr.182.1.1820173. AJR Am J Roentgenol. 2004. PMID: 14684535 Review. No abstract available.
Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients.
D'Huyvetter M, Vos J, Caveliers V, Vaneycken I, Heemskerk J, Duhoux FP, Fontaine C, Vanhoeij M, Windhorst AD, Aa FV, Hendrikse NH, Eersels JLE, Everaert H, Gykiere P, Devoogdt N, Raes G, Lahoutte T, Keyaerts M. D'Huyvetter M, et al. Among authors: everaert h. J Nucl Med. 2021 Aug 1;62(8):1097-1105. doi: 10.2967/jnumed.120.255679. Epub 2020 Dec 4. J Nucl Med. 2021. PMID: 33277400 Free article.
116 results